Comprehensive review: antitumor necrosis factor agents in inflammatory bowel disease and factors implicated in treatment response
GR Lichtenstein - Therapeutic advances in gastroenterology, 2013 - journals.sagepub.com
Antitumor necrosis factor α (anti-TNF) agents have dramatically influenced management of
refractory inflammatory bowel disease (IBD). However, not all patients respond to treatment …
refractory inflammatory bowel disease (IBD). However, not all patients respond to treatment …
Comprehensive review: antitumor necrosis factor agents in inflammatory bowel disease and factors implicated in treatment response.
GR Lichtenstein - Therapeutic Advances in …, 2013 - search.ebscohost.com
Antitumor necrosis factor α (anti-TNF) agents have dramatically influenced management of
refractory inflammatory bowel disease (IBD). However, not all patients respond to treatment …
refractory inflammatory bowel disease (IBD). However, not all patients respond to treatment …
Comprehensive review: antitumor necrosis factor agents in inflammatory bowel disease and factors implicated in treatment response
GR Lichtenstein - Therapeutic advances in …, 2013 - pubmed.ncbi.nlm.nih.gov
Antitumor necrosis factor α (anti-TNF) agents have dramatically influenced management of
refractory inflammatory bowel disease (IBD). However, not all patients respond to treatment …
refractory inflammatory bowel disease (IBD). However, not all patients respond to treatment …
Comprehensive review: antitumor necrosis factor agents in inflammatory bowel disease and factors implicated in treatment response.
GR Lichtenstein - Therapeutic Advances in Gastroenterology, 2013 - europepmc.org
Antitumor necrosis factor α (anti-TNF) agents have dramatically influenced management of
refractory inflammatory bowel disease (IBD). However, not all patients respond to treatment …
refractory inflammatory bowel disease (IBD). However, not all patients respond to treatment …
[HTML][HTML] Comprehensive review: antitumor necrosis factor agents in inflammatory bowel disease and factors implicated in treatment response
GR Lichtenstein - Therapeutic Advances in Gastroenterology, 2013 - ncbi.nlm.nih.gov
Antitumor necrosis factor α (anti-TNF) agents have dramatically influenced management of
refractory inflammatory bowel disease (IBD). However, not all patients respond to treatment …
refractory inflammatory bowel disease (IBD). However, not all patients respond to treatment …